Interferometric Exosome Detection via LED Illumination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting nanomolecular particles, such as exosomes associated with cancer, lack sensitivity and specificity, hindering early and accurate diagnosis and disease staging.
Innovation Solution
A method and device utilizing glypican-positive exosomes as a diagnostic tool, involving a substrate with binding agents specific for glypican-1, employing interferometric principles with low-cost LED illumination for high-throughput detection and imaging of extracellular vesicles, enabling label-free, high-magnification analysis of biomarkers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional detection methods are used for nanomolecular particles, then the detection process is simple, but the sensitivity and specificity are insufficient
Solution Approach 1:
The patent employs interferometric detection as an intermediary mechanism between the exosomes and the detection system. The interferometric setup uses reference and sample beams that interfere upon reflection from the substrate surface, creating measurable intensity patterns that indicate exosome binding. This intermediary optical mechanism enables high sensitivity detection without requiring complex labeling or amplification systems.
Solution Approach 2:
The patent replaces conventional mechanical or chemical detection methods with optical interferometric detection. Instead of using complex mechanical sensors or chemical assays, the system uses light interference patterns to detect exosome binding events, achieving high sensitivity through optical field interactions rather than mechanical or chemical measurements.
2Measurement precision
If high-sensitivity detection methods are used, then detection accuracy improves, but the cost and portability deteriorate
Solution Approach 1:
The patent employs inexpensive LED light sources instead of costly laser systems, making the interferometric detection device affordable and suitable for widespread deployment. The use of standard optical components and simple substrate structures further reduces manufacturing costs, enabling portable and cost-effective high-sensitivity detection systems.
Solution Approach 2:
The patent extracts the essential detection function from complex conventional systems by using a simplified interferometric setup with LED illumination. By removing unnecessary complexity and focusing on the core interferometric measurement principle, the system achieves high detection accuracy while maintaining cost-effectiveness and portability.
3Device complexity
If label-free detection is implemented, then the detection process is simplified, but the signal detection difficulty increases
Solution Approach 1:
The patent uses optical field interference as an analog to vibration detection, where the interferometric setup creates measurable intensity variations (optical 'vibrations') upon exosome binding. The reference and sample beams interfere constructively or destructively, producing detectable intensity patterns that amplify the weak binding signal without requiring labels.
Solution Approach 2:
The interferometric detection method detects changes in optical intensity patterns (analogous to color changes) that occur when exosomes bind to the substrate. The interference pattern modifications provide a visible, label-free signal that simplifies the detection process while maintaining high sensitivity to binding events.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for sensitive and specific detection of cancer-derived exosomes, facilitating early diagnosis and monitoring of cancer progression with cost-effective, portable, and high-throughput capabilities.
Implementation Method 1
binding of a nanoparticle target to a binding agent on a surface of a substrate alters an optical path length relative to an optical path length in the absence of the nanoparticle target, resulting in an interference pattern that is detected and measured
Data Source
AI summary
A spectral reflectance imaging device for detecting nanoparticle exosome biomarker targets includes an illumination source that illuminates a substrate with a plurality of separate wavelengths of incoherent light. The substrate includes an oxide layer and a binding agent to selectively bind nanoparticle exosome biomarker targets to the substrate. An imaging device bindings the light reflected from or transmitted through the substrate and an image processing system detects the nanoparticle exosome biomarker targets a function of the change in reflective properties of the substrate.